dividends

NYSE · GRFS
Grifols, S.A.
Healthcare · Drug Manufacturers - General
$8.10
Up+$0.06 (+0.75%)
Updated Nov 2, 2026, 10:58 AM
SID Score
5.9/10
Composite research score
Smart Money
56/100
Neutral
- Market cap
- 7.74B
- P/E ratio
- 24.94
- Dividend yield
- 2.14%
- 52-week range
- $6.96 – $9.77
- Volume
- 803.38K
- Avg. volume
- 623.71K
Price performance · GRFS
GRFS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
GRFS closed at $8.10 after 20 trading sessions, up 9.31% for the selected period.
- Last close
- $8.10
- Period change
- +9.31%
- Period low
- $7.17
- Period high
- $8.12
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $8.10 | $8.2487 | $8.05 | $8.10 | 803.38K |
| Oct 29, 2026 | $8.12 | $8.14 | $7.995 | $8.04 | 273.39K |
| Oct 28, 2026 | $7.95 | $8.30 | $7.90 | $8.12 | 969.08K |
| Oct 27, 2026 | $7.89 | $8.13 | $7.88 | $8.10 | 840.52K |
| Oct 26, 2026 | $7.76 | $8.11 | $7.76 | $7.92 | 845.89K |
| Oct 23, 2026 | $7.50 | $7.5688 | $7.4907 | $7.56 | 992.34K |
| Oct 22, 2026 | $7.42 | $7.49 | $7.37 | $7.45 | 482.55K |
| Oct 21, 2026 | $7.51 | $7.59 | $7.48 | $7.50 | 310.9K |
| Oct 20, 2026 | $7.61 | $7.695 | $7.52 | $7.54 | 369.08K |
| Oct 19, 2026 | $7.52 | $7.67 | $7.50 | $7.64 | 1.46M |
| Oct 16, 2026 | $7.59 | $7.75 | $7.57 | $7.64 | 872.36K |
| Oct 15, 2026 | $7.51 | $7.56 | $7.40 | $7.54 | 907.08K |
| Oct 14, 2026 | $7.29 | $7.40 | $7.22 | $7.24 | 538.5K |
| Oct 13, 2026 | $7.36 | $7.36 | $7.15 | $7.17 | 439.64K |
| Oct 12, 2026 | $7.52 | $7.52 | $7.36 | $7.37 | 266.11K |
| Oct 9, 2026 | $7.51 | $7.53 | $7.44 | $7.46 | 330.56K |
| Oct 8, 2026 | $7.42 | $7.45 | $7.2839 | $7.41 | 368.07K |
| Oct 7, 2026 | $7.48 | $7.56 | $7.44 | $7.50 | 260.7K |
| Oct 6, 2026 | $7.53 | $7.565 | $7.415 | $7.52 | 326.1K |
| Oct 5, 2026 | $7.31 | $7.54 | $7.29 | $7.41 | 492.77K |
Latest GRFS news
The latest Smart Investors Daily articles mentioning GRFS.
Stock researchCompany · Dividend
Company
Market Activity
Research & News
Loading stock research…

